Check up: A good fortnight to be a small cap health investor

Pic: Oscar Wong / Moment via Getty Images
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 133-odd small cap health stocks and of those which were trading on Wednesday, 90 were in positive territory over the last fortnight, 13 were flat and 33 saw their share prices fall.
Code Name Price $ (August 19) 2 week return % 1 year return % Market cap FTT FACTOR THERAPEUTICS LTD 0.005 67 67 $5,214,178 NTI NEUROTECH INTERNATIONAL LTD 0.016 60 -6 $3,959,450 IBX IMAGION BIOSYSTEMS LTD 0.081 60 75 $71,641,960 KZA KAZIA THERAPEUTICS LTD 0.83 59 134 $77,570,664 CDX CARDIEX LTD 0.055 57 139 $46,073,580 BNO BIONOMICS LTD 0.12 57 192 $65,749,516 BPH BPH ENERGY LTD 0.032 45 234 $13,951,561 RHY RHYTHM BIOSCIENCES LTD 0.115 44 -27 $16,648,938 ANR ANATARA LIFESCIENCES LTD 0.2 41 -17 $9,472,674 CPH CRESO PHARMA LTD 0.041 35 -90 $15,388,018 ATH ALTERITY THERAPEUTICS LTD 0.062 35 114 $67,270,248 UBI UNIVERSAL BIOSENSORS INC-CDI 0.325 30 63 $57,710,852 PXS PHARMAXIS LTD 0.11 29 -45 $43,477,960 DXB DIMERIX LTD 0.6 28 532 $118,649,576 MEM MEMPHASYS LTD 0.135 27 175 $105,556,344 CGS COGSTATE LTD 0.73 27 288 $124,205,968 CYP CYNATA THERAPEUTICS LTD 0.81 25 -52 $92,527,960 PAA PHARMAUST LTD 0.24 24 177 $72,587,096 LCT LIVING CELL TECHNOLOGIES LTD 0.017 21 -23 $9,714,497 OCC ORTHOCELL LTD 0.42 21 8 $79,458,392 ALT ANALYTICA LTD 0.003 20 -25 $10,558,837 RSH RESPIRI LTD 0.155 19 57 $101,190,168 MXC MGC PHARMACEUTICALS LTD 0.026 18 -48 $42,416,840 MDC MEDLAB CLINICAL LTD 0.17 18 -64 $46,146,484 VBS VECTUS BIOSYSTEMS LTD 0.8 18 51 $18,923,852 NYR NYRADA INC-CDI 0.215 16 $23,517,500 AGH ALTHEA GROUP HOLDINGS LTD 0.375 16 -55 $86,324,704 PIQ PROTEOMICS INTERNATIONAL LAB 0.655 15 143 $60,525,848 TLX TELIX PHARMACEUTICALS LTD 1.4 15 9 $368,219,424 NXS NEXT SCIENCE LTD 1.52 14 -45 $268,689,088 SVA SIMAVITA LTD-CDI 0.024 14 100 $27,692,782 AVE AVECHO BIOTECHNOLOGY LTD 0.008 14 100 $12,779,659 VLS VITA LIFE SCIENCES LTD 0.705 14 4 $38,128,240 IDT IDT AUSTRALIA LTD 0.18 13 29 $43,076,344 RNO RHINOMED LTD 0.084 12 -72 $21,319,968 SUD SUDA PHARMACEUTICALS LTD 0.048 12 -50 $14,680,654 IVX INVION LTD 0.01 11 -33 $55,035,988 OIL OPTISCAN IMAGING LTD 0.051 11 21 $24,366,718 NC6 NANOLLOSE LTD 0.053 10 -31 $5,604,750 GLH GLOBAL HEALTH LTD 0.27 10 92 $11,366,546 ONT 1300 SMILES LTD 6.53 10 12 $154,619,840 JHL JAYEX HEALTHCARE LTD 0.033 10 -3 $5,819,980 OSP OSPREY MEDICAL INC-CDI 0.035 10 -45 $50,958,820 ZNO ZOONO GROUP LTD 2.4 10 3378 $392,670,496 SOM SOMNOMED LTD 1.43 9 -16 $118,345,824 M7T MACH7 TECHNOLOGIES LTD 0.98 9 26 $229,689,168 HLA HEALTHIA LTD 0.975 8 3 $61,458,788 SCU STEMCELL UNITED LTD 0.013 8 -19 $8,340,909 NOX NOXOPHARM LTD 0.33 8 -8 $70,369,392 CMP COMPUMEDICS LTD 0.48 8 -34 $83,266,584 MVP MEDICAL DEVELOPMENTS INTERNA 6.65 8 36 $410,146,816 ALC ALCIDION GROUP LTD 0.14 8 -10 $138,697,168 RGS REGENEUS LTD 0.165 8 77 $38,895,500 CAN CANN GROUP LTD 0.49 8 -73 $95,645,336 ICS ICSGLOBAL LTD 1.89 7 122 $20,041,596 VTI VISIONEERING TECH-CDI 0.016 7 -70 $15,509,062 IPD IMPEDIMED LTD 0.08 7 -39 $82,794,344 CYC CYCLOPHARM LTD 1.5 6 11 $120,411,680 BOT BOTANIX PHARMACEUTICALS LTD 0.053 6 -75 $52,525,696 AT1 ATOMO DIAGNOSTICS LTD 0.38 6 $210,404,176 MVF MONASH IVF GROUP LTD 0.555 6 -54 $220,143,680 1AD ADALTA LTD 0.11 6 -7 $24,068,542 IMC IMMURON LTD 0.38 5 259 $88,519,504 IMM IMMUTEP LTD 0.195 5 -9 $97,526,184 PTX PRESCIENT THERAPEUTICS LTD 0.065 5 51 $24,444,158 OSL ONCOSIL MEDICAL LTD 0.115 5 89 $95,289,104 AMT ALLEGRA ORTHOPAEDICS LTD 0.235 4 96 $24,532,246 DVL DORSAVI LTD 0.025 4 -41 $5,554,261 PYC PYC THERAPEUTICS LTD 0.12 4 243 $351,789,344 NSB NEUROSCIENTIFIC BIOPHARMACEU 0.24 4 0 $18,812,300 TD1 TALI DIGITAL LTD 0.027 4 200 $20,231,240 RHT RESONANCE HEALTH LTD 0.145 4 32 $64,347,220 AC8 AUSCANN GROUP HOLDINGS LTD 0.15 3 -59 $47,557,104 ATX AMPLIA THERAPEUTICS LTD 0.15 3 98 $17,945,120 BD1 BARD1 LIFE SCIENCES LTD 0.032 3 10 $76,624,976 ACR ACRUX LTD 0.175 3 -9 $26,986,474 AHX APIAM ANIMAL HEALTH LTD 0.51 3 23 $58,881,552 PGC PARAGON CARE LTD 0.175 3 -61 $59,129,928 CTE CRYOSITE LTD 0.185 3 270 $8,669,019 PBP PROBIOTEC LTD 2.07 2 37 $154,792,256 CAJ CAPITOL HEALTH LTD 0.21 2 -1 $219,858,400 JHC JAPARA HEALTHCARE LTD 0.485 2 -51 $126,942,480 RAC RACE ONCOLOGY LTD 0.9 2 1277 $115,247,896 PAL PALLA PHARMA LTD 0.895 2 -20 $112,723,440 OSX OSTEOPORE LTD 0.61 2 $61,750,608 HCT HOLISTA COLLTECH LTD 0.068 1 19 $18,723,738 SDX SIENNA CANCER DIAGNOSTICS LT 0.07 1 17 ICR INTELICARE HOLDINGS LTD 0.38 1 $27,701,888 PSQ PACIFIC SMILES GROUP LTD 1.45 1 21 $222,597,552 ACW ACTINOGEN MEDICAL LTD 0.026 0 213 $27,905,784 RAP RESAPP HEALTH LTD 0.135 0 -10 $105,716,728 BXN BIOXYNE LTD 0.011 0 -42 $7,041,600 ANP ANTISENSE THERAPEUTICS LTD 0.078 0 54 $39,119,052 EYE NOVA EYE MEDICAL LTD 0.31 0 12 $44,516,352 NEU NEUREN PHARMACEUTICALS LTD 1.3 0 -3 $152,890,544 PAB PATRYS LTD 0.013 0 -43 $18,591,574 IMU IMUGENE LTD 0.056 0 162 $246,557,440 GTG GENETIC TECHNOLOGIES LTD 0.0095 0 168 $82,617,264 EXL ELIXINOL GLOBAL LTD 0.165 0 -92 $31,818,116 ADR ADHERIUM LTD 0.03 0 58 $19,944,358 BWX BWX LTD 4.145 0 82 $580,503,040 VHT VOLPARA HEALTH TECHNOLOGIES 1.37 0 -4 $332,881,024 RCE RECCE PHARMACEUTICALS LTD 1.29 -1 502 $186,698,592 OPT OPTHEA LTD 2.45 -1 -8 $654,053,376 OVN OVENTUS MEDICAL LTD 0.265 -2 -41 $41,939,540 MDR MEDADVISOR LTD 0.485 -2 46 $118,424,656 MMJ MMJ GROUP HOLDINGS LTD 0.095 -2 -61 $21,845,628 PNV POLYNOVO LTD 2.205 -2 50 $1,474,226,304 ARX AROA BIOSURGERY LTD 1.4 -2 $417,104,192 SDI SDI LTD 0.68 -3 -3 $80,828,560 MEB MEDIBIO LTD 0.011 -4 -21 $15,498,119 UCM USCOM LTD 0.205 -5 105 $30,714,808 BIT BIOTRON LTD 0.1 -5 37 $70,193,272 ESE ESENSE-LAB LTD-CDI 0.018 -5 -31 $9,180,684 FFC FARMAFORCE LTD 0.052 -5 -65 $6,696,091 1ST 1ST GROUP LTD 0.035 -6 -56 $14,436,975 ADO ANTEOTECH LTD 0.052 -6 301 $85,380,048 LBT LBT INNOVATIONS LTD 0.145 -6 41 $41,806,376 THC THC GLOBAL GROUP LTD 0.255 -7 -41 $44,152,908 IHL INCANNEX HEALTHCARE LTD 0.064 -8 -25 $46,876,668 CDY CELLMID LTD 0.11 -8 -48 $13,777,155 ZLD ZELIRA THERAPEUTICS LTD 0.054 -8 -18 $61,683,444 PAR PARADIGM BIOPHARMACEUTICALS 2.72 -9 91 $624,145,984 AZV AZURE HEALTHCARE LTD 0.07 -9 -12 $19,893,226 GSS GENETIC SIGNATURES LTD 2.24 -9 110 $328,005,280 S66 STAR COMBO PHARMA LTD 0.33 -10 -42 $44,753,480 LSH LIFESPOT HEALTH LTD 0.036 -10 -47 $3,516,246 MX1 MICRO-X LTD 0.16 -11 -45 $57,146,856 APH AUSTRALIAN PRIMARY HEMP LTD 0.14 -13 -36 $9,765,719 CP1 CANNPAL ANIMAL THERAPEUTICS 0.115 -18 -32 $10,709,375 PCK PAINCHEK LTD 0.11 -21 -41 $123,948,528 ONE ONEVIEW HEALTHCARE PLC-CDI 0.052 -33 -74 $9,006,997 GMV G MEDICAL INNOVATION HOLDING 0.042 -33 -65 $35,230,928
While the numbers weren’t high — let’s face it, small caps are capable of much more than a piddly 67 per cent rise in a fortnight — there were a lot of them in positive territory.
Not only have the health and life sciences players been delivering good news generally, but they’re also proving to be a good source of annual results.
But this fortnight, there’s been little rhyme or reason for the large scale upwards moves except that people are buying life sciences stocks.
Factor Therapeutics (ASX:FTT) investors were still buzzing about the company’s transformation into an animal imaging outfit, after that clinical trial which led to a near wipe out of the company’s value.
And clearly news leaked before Neurotech International (ASX:NTI) was able to go into a trading halt. It is still in the process of working out what to tell the ASX and how to release results of lab testing of its cannabis strains.
Imagion Biosystems (ASX:IBX) was all innocence last week when asked why its stock was rising so fast. One theory could be latecomers discovering the Imagion-tesla link.
While other companies may prefer to stay mum on why their stock is moving, BPH Energy (ASX:BPH) is one entity that always has an answer.
In this case the company claimed it was the non-life sciences arm doing the heavy lifting: “BPH notes that the National Offshore Petroleum Titles Administrator (NOPTA) has confirmed on its website that the application currently made by the Joint Venture Participants BUY and BPH for a suspension, variation and extension to the permit terms for PEP11 is in the final phase of decision process and is now with the Joint Authority for decision.”
With a bird flu outbreak underway in Victoria (factory farmed chickens aren’t great at social distancing), Anatara Lifesciences (ASX:ANR) was looking for partners to trial its necrotic enteritis, or chicken gastro, treatment.
It has since done a deal with the University of New England’s Poultry Hub Australia.
Coming in at #13 in the Check Up rankings is Pharmaxis (ASX:PXS), which actually had news that investors could (and were) buying into.
The Food and Drug Administration (FDA) completed a safety review of the company’s Investigational New Drug (IND) application for its pan‐LOX inhibitor PXS‐5505 and gave permission to proceed with a phase 1/2 clinical trial for treating myelofibrosis in adults.
The study is planned to start in the December quarter and expected to conclude in 2022.
And finally sperm separator Memphasys (ASX:MEM) has done a collaboration with Newcastle University to develop new products in niche reproductive biology applications.
With the Felix device on track for commercialisation later this year, Memphasys is now looking to extend its pipeline of products into diagnostics for animal fertility and semen oxidative stress, and development of long life sperm storage media.
Related Topics

SUBSCRIBE
Get the latest breaking news and stocks straight to your inbox.
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.